Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06886477 · ClinicalTrials.gov registry record · NA

Sickle Cell, Pain and Mediterranean Diet

A NA study of Sickle Cell Disease and Sickle Cell, sponsored by University of Illinois at Chicago.

Active
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT06886477 is a NA study of Sickle Cell Disease and Sickle Cell that is active but no longer recruiting, run by University of Illinois at Chicago. The registered enrollment target is 28 participants, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06886477, a NA study of Sickle Cell Disease and Sickle Cell, is active but no longer recruiting, sponsored by University of Illinois at Chicago.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to compare pain levels in individuals with Sickle Cell Disease while following the Mediterranean Diet to pain levels while following their usual diet.

Interventions

  • OTHER Usual Diet
  • OTHER Mediterranean Diet

Study Locations (1)

Illinois

  • University of Illinois Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2025-05-01
Est. Completion 2026-12-31
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT06886477

The ClinicalTrials.gov registry entry for NCT06886477 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (90% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Sickle Cell Disease appearing as the primary indexed condition, and to 2 interventions - of which Usual Diet is the first listed.

NCT06886477 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06886477 about?

NCT06886477 is a clinical study titled "Sickle Cell, Pain and Mediterranean Diet". The goal of this study is to compare pain levels in individuals with Sickle Cell Disease while following the Mediterranean Diet to pain levels while following their usual diet.

What is the current status of trial NCT06886477?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2025-05-01. Estimated completion is 2026-12-31.

What conditions does trial NCT06886477 study?

This clinical trial studies the following conditions: Sickle Cell Disease, Sickle Cell, Sickle Cell Disease Without Crisis, Mediterranean Diet.

What interventions are being tested in trial NCT06886477?

The interventions under investigation include: Usual Diet (OTHER), Mediterranean Diet (OTHER).

Who is sponsoring clinical trial NCT06886477?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06886477 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sickle Cell Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.